Gleason Score of 3+4 is not equal to 4+3 in Lethal Prostate Cancer

When diagnosed I was told that I had a Gleason score of 7, calculated by adding the first number, a descriptor of the most prevalent cancer cells in the biopsy sample, to the second number, a descriptor for the second most prevalent cancer cells. In my case the actual Gleason score was 4+3 or a [...]

Who Knows? A Possible New Approach for Treating Recurrent Prostate Cancer on the Horizon

There is a new study that shows that an alpha-particle emitting radiopeptide—radioactive material bound to a synthetic peptide, a component of protein—is effective for treating prostate cancer in mice, according to researchers. The conclusions of this study could eventually (still years away if it also works in men) result in a significant breakthrough in advanced [...]

APPROPRIATORS QUESTION PRESIDENT’S PLAN TO DOUBLE FUNDING FOR CANCER RESEARCH – IS CANCER RESEARCH THREATENED?

The fairness of increasing cancer research funding in FY2010 comes into question during House and Senate hearings. See my post of May 23, 2009: Senator Harkin and the Senate Appropriations subcommittee on Labor, Health and Human Services, and Education Hold Hearings on the Budget Allocations to the NCI for Cancer Research Two leading appropriators in [...]

What is a Good Prostate Cancer Diet?

What is a good prostate cancer diet? In reality, there is no overwhelming, big sample size studies that we can point to that provides actual scientific, statistically significant evidence of being the “best.” However, many small studies point to the better diet (better than the typical western diet full of red meat and processed sugars). [...]

We Need an Office Of Men’s Health

Mike Scott from the New Prostate Cancer Info Link has sent an email to many members of the leadership of the prostate cancer community letting us know about an opportunity to provide feedback to the federal government asking that there be an office of Men’s Health established. The following is a copy of Mike’s complete [...]

Go to Top